创金合信全球医药生物股票发起(QDII)C(018156)持股变动
| 序号 |
股票代码 |
股票简称 |
变动数量(股) |
变动市值(元) |
变动类型 |
| 1 |
NKTR |
内克塔治疗 |
27,891.00 |
11,373,297.97 |
新增 |
| 2 |
DFTX |
Definium Therapeutics Inc |
44,000.00 |
11,278,867.86 |
新增 |
| 3 |
SYRE |
Spyre Therapeutics Inc |
18,495.00 |
11,090,082.00 |
新增 |
| 4 |
URGN |
乌龙制药 |
40,000.00 |
10,945,884.52 |
新增 |
| 5 |
CYTK |
Cytokinetics Inc |
14,160.00 |
4,621,697.78 |
仓增 |
| 6 |
KRYS |
Krystal Biotech Inc |
2,240.00 |
4,200,777.10 |
仓增 |
| 7 |
ORIC |
Oric Pharmaceuticals Inc |
24,800.00 |
3,878,036.57 |
仓增 |
| 8 |
COGT |
Cogent Biosciences Inc |
18,755.00 |
2,380,074.24 |
仓增 |
| 9 |
PTGX |
Protagonist Therapeutics Inc |
0.00 |
1,505,855.31 |
持有 |
| 10 |
EWTX |
Edgewise Therapeutics Inc |
438.00 |
-18,299.96 |
仓增 |